A short social post says GLP-1 drugs are helping millions of Americans lose weight while their long-term safety is still uncertain. No new data is given.
Recap by typeshit. Post by @TND on X.
A patient stopped Wegovy for weeks around surgery and asks others whether symptoms returned when they came off it.
One user says her period returned after two months on tirzepatide without medroxyprogesterone and asks others to compare.
She singles out products sold as retatrutide as especially dangerous, part of the growing pushback on gray-market peptide sellers.
In Touch Weekly reports the March 2025 death was caused by anaphylaxis and was Australia's first death of its kind linked to anti-aging drugs.
Users describe cheap retatrutide from Chinese suppliers, and a lab chemist says some tested vials held wrong doses or an unknown peptide.
The Independent Medical Alliance doctor weighs in on what is still unknown about the long-term safety of GLP-1 drugs used by millions of Americans.
Loading…